Emicizumab

Red

Brand Name(s):Hemlibra

Indication:Haemophilia A with factor VIII inhibitors(routine prophylaxis of bleeding episodes)

Rationale:1,2,3

Considered:Mar-18

Review Date:Mar-23

Comments: